Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 21, 2013 (13 years ago)

Gastrografin

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of foreign substance: One lot of the product may contain black foreign particles

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution), USP, 37% Organically Bound Iodine, 120 ml bottle, Rx only, Manufactured for Bracco Diagnostics Inc. Princeton, NJ 08543 by Therapex, Division of E-Z-EM Canada Inc. Anjou Quebec H1J2Z4, Canada, NDC 0270-0445-40

Affected NDC 0270-0445-40

Compare with the code on your package — it is the most precise check available.

Drug: Iodine

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Gastrografin
diatrizoate meglumine and diatrizoate sodium
NDC 00270-0445
DIATRIZOATE MEGLUMINE 660 mg/mL; DIATRIZOATE SODIUM 100 mg/mL Liquid
Oral|rectal
Bracco Diagnostics Inc Rx
Recalling firm
Bracco Diagnostics Inc
NDC code
0270-0445-40
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-885-2013 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Iodine recalls

See all
Class II · Moderate risk

BD PurPrep

Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-42 D-0644-2026
Class II · Moderate risk

BD PurPrep

Lack of assurance of Sterility: potential product contamination

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-014-41 D-0518-2026

Other recalls by Bracco Diagnostics Inc

All 2013 recalls
Class II · Moderate risk

E-Z-Paste Barium Sulfate Esophageal Cream

Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.

Terminated Stability / shelf life Bracco Diagnostics Inc. NDC 32909-770-01 D-0609-2018
Class III · Low risk

Tagitol V Barium Sulfate Suspension

Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.

Terminated Stability / shelf life Bracco Diagnostics Inc NDC 32909-814-53 D-914-2013
Class II · Moderate risk

Cardiogen-82

GMP deviation; Sr-82 levels exceeded alert limit specification

Terminated cGMP deviation Bracco Diagnostics Inc NDC 0270-0091-01 D-1684-2012